Apellis Pharmaceuticals Inc Quick ratio

Qual é o Quick ratio de Apellis Pharmaceuticals Inc?

O Quick ratio de Apellis Pharmaceuticals Inc é 4.04

Qual é a definição de Quick ratio?



Liquidez Reduzida é o indicador de liquidez que mede a capacidade de uma empresa de usar seus ativos rápidos para cumprir suas obrigações de curto prazo imediatamente.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio de empresas na Setor Health Care em NASDAQ em comparação com Apellis Pharmaceuticals Inc

O que Apellis Pharmaceuticals Inc faz?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Empresas com quick ratio semelhantes a Apellis Pharmaceuticals Inc